Biogen’s Alzheimer’s drug: What’s the price tag on hope?
World of DTC Marketing
JUNE 1, 2021
Kesselheim, a professor of medicine at Harvard Medical School via the Washington Post , says “the worst thing for people with Alzheimer’s would be to put out a product that doesn’t work.” After the CEO departed the sinking ship, new management pinned all their hopes on the Biogen drug for Alzheimer’s.
Let's personalize your content